✨ Free AI Report
Retractable Technologies, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Retractable Technologies, Inc.
Company Research

Retractable Technologies, Inc.: Business Overview, Financials & Competitive Analysis

Retractable Technologies, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Specialized safety medical device company with unique technology but limited scale and profitability. While Retractable Technologies operates in a defensible niche market with specialized safety syringe technology, the company faces significant headwinds including minimal analyst coverage, micro-cap valuation under $25M, and unprofitability. The strong insider buying by CEO Thomas.

What is Retractable Technologies, Inc.'s industry? Retractable Technologies, Inc. (retractable.com) operates in Medical Devices - Safety Injection Devices & Syringes. AskCyborg classifies Retractable Technologies, Inc. under Medical Devices - Safety Injection Devices & Syringes in its company registry.

Retractable Technologies designs, develops, manufactures, and markets safety syringes and medical injection devices for the healthcare industry. The company specializes in needlestick injury prevention through retract...

4/ 10Mixed

Cyborg Score thesis

Specialized safety medical device company with unique technology but limited scale and...

Read the full analyst-debate transcript →
Industry Medical Devices - Safety Injection Devices & Syringes
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Retractable Technologies, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Retractable Technologies, Inc.

AskCyborg analysts argue the bull and bear cases for Retractable Technologies, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Retractable Technologies, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Retractable Technologies, Inc. Overview

Pro stress-test →

Retractable Technologies designs, develops, manufactures, and markets safety syringes and medical injection devices for the healthcare industry. The company specializes in needlestick injury prevention through retractable needle technology, serving markets across North America and internationally.

Strategic Profile

Pro stress-test →

The company competes in the specialized medical device segment with proprietary VanishPoint, Patient Safe, and EasyPoint branded products. As a micro-cap with significant insider ownership, leadership has demonstrated confidence through substantial share purchases, though the company faces challenges as a thinly-traded OTC equity.

Competitive Landscape

Pro stress-test →

Retractable Technologies competes with larger medical device manufacturers in the safety syringe space, including established players in injection device markets. The company differentiates through proprietary retractable needle technology and specialized focus on needlestick injury prevention, occupying a niche segment with limited direct competition.

Industry Context

Retractable Technologies, Inc. operates in Medical Devices - Safety Injection Devices & Syringes.

Key facts

Founded: 1994 · Headquarters: Little Elm, TX · Employees: N/A · Revenue: N/A · Market cap: $24.9M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Retractable Technologies, Inc..

  • CEO Thomas Shaw has made substantial insider purchases over recent years, accumulating over $800K worth of shares at prices between $0.60-$0.80
  • Company operates with near-zero analyst coverage and minimal institutional interest, creating information asymmetry
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • November 2025CEO acquisition of 5,731 shares, continuing pattern of insider buying
  • September 2025Significant insider purchasing activity noted with multiple share acquisitions
  • +1 moreTrack every material event for Retractable Technologies, Inc. as it happens. Explore monitoring →
Get alerted when Retractable Technologies, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Safety syringes and injection devicesLarge-cap medical device manufacturer with broad safety product portfolio→Safety injection devicesHealthcare services and products distributor with safety device offerings→Specialty medical devicesMid-cap medical device company with injection and infusion device portfolio→

Compare Retractable Technologies, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Retractable Technologies, Inc. operates in Medical Devices - Safety Injection Devices & Syringes. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Safety Injection Devices & Syringes research →
NEW · MCP server

Ask your AI assistant about Retractable Technologies, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Retractable Technologies, Inc. and its top competitor on Cyborg Score”
“What did Retractable Technologies, Inc. do this quarter?”
“Is Retractable Technologies, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Retractable Technologies, Inc. do?+
Retractable Technologies designs, develops, manufactures, and markets safety syringes and medical injection devices for the healthcare industry. The company specializes in needlestick injury prevention through retract...
What is Retractable Technologies, Inc.'s Cyborg Score?+
Retractable Technologies, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Retractable Technologies, Inc.'s main competitors?+
Named competitors include Safety syringes and injection devices, Safety injection devices, Specialty medical devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Retractable Technologies, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Retractable Technologies, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Retractable Technologies, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.